Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3450-3456

  Durkan, Garrett C ^a   Nutt, Joyce E ^a   Rajjayabun, Paul H ^a   Neal, David E ^a   Lunec, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; URINALYSIS; URINARY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; URINARY BLADDER NEOPLASMS;

EID: 0035186345     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Contributions of tumour and stromal matrix metalloproteinases to tumour progression, invasion and metastasis
2. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells
3. The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridisation with early stage melanoma cells
4. Changing views of the role of matrix metalloproteinases in metastasis
5. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor
6. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
7. A new inhibitor of metalloproteinase from chicken: CHIMP-3
8. Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase-4
9. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
10. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer
11. Collagenase-a marker enzyme in human bladder cancer?
12. Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder cell lines and is detectable in urine of patients with bladder tumours
13. Increased matrix metalloproteinase-1 (MMP-1) activity in transitional cell carcinoma (TCC) predicts a significantly increased risk of death
14. Tumour invasion and metastasis: An imbalance of positive and negative regulation
15. Tissue inhibitors of metalloproteinases and their cell growth-promoting activity
16. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonisation by murine B16-F10 melanoma cells
17. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumour cells leading to increased levels of collagenase activity
18. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer
19. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
20. High levels of messanger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with the development of distant metastases
21. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcimona
22. TIMP-1 and adverse prognosis in non-small cell lung cancer
23. Elevated tissue inhibitor of metalloproteinase-1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases
24. High levels of tissue inhibitors of metalloproteinase-1 predict poor outcome in patients with breast cancer
25. Matrix metalloproteinase 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
26. Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients
27. International histological classification of tumours. A report by the Executive Committee of the International Council of Societies of Pathology
28. Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme linked immunosorbent assay to measure total collagenase
29. Role of matrix metalloproteinase-9 in basement membrane destruction of superficial urothelial carcinomas
30. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA)
31. Regulation of tissue inhibitor of metalloproteinase-1 expression
32. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
33. A fibrosarcoma model derived from mouse embryo cells: Growth properties and secretion of collagenase and metalloproteinases inhibitor (TIMP-1) by tumour cell lines
34. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
35. Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
36. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity
37. K562 cells produce and respond to human erythroid potentiating activity
38. Tissue inhibitor of metalloprotease (TIMP-1) and proliferative behaviour of clonal breast cancer cells
39. Tissue inhibitors of metalloproteinases: Role in tumour progression
40. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular permeability
41. Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts